PEG-ADRIB

PEG-ADRIB

Therapeutic Class: Anti-Neoplastic

Indication: Ovarian Cancer, AIDS-related Kaposi sarcoma, Multiple Myeloma

Pegylated liposomal anthracycline formulation. Depending on the approved indication, used in ovarian cancer, AIDS-related Kaposi sarcoma and multiple myeloma. The liposomal formulation should not be substituted for conventional doxorubicin HCl.

As prescribed by Physician

2–8°C, refrigerate unopened vial. Do not freeze. Single-dose vial; discard unused portion

Copyright 2025. All Right Reserved